2-(Imidazo[2,1-b]thiazol-6-yl)acetic acid hydrochloride

Catalog No.: 
ACRVQQ038
CAS No.: 
57626-36-5
Molecular Formula: 
C7H7ClN2O2S
Molecular Weight: 
218.66
2-(Imidazo[2,1-b]thiazol-6-yl)acetic acid hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%
250mg98%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Imidazo[2,1-b]thiazol-6-yl)acetic acid hydrochloride
IUPAC Name2-(Imidazo[2,1-b]thiazol-6-yl)acetic acid hydrochloride
MDL No.MFCD31620032
Molecular FormulaC7H7ClN2O2S
Molecular Weight218.66
SMILESO=C(O)CC1=CN2C(SC=C2)=N1.[H]Cl
InChI KeyWYPSVWGIDWIHPX-UHFFFAOYSA-N
SynonymImidazo[2,1-b][1,3]thiazol-6-ylacetic acid hydrochloride hydrate;2-(Imidazo[2,1-b]thiazol-6-yl)acetic acid hydrochloride;2-{Imidazo[2,1-b][1,3]thiazol-6-yl}acetic Acid Hydrochloride;Imidazo[2,1-b]thiazole-6-acetic acid hydrochloride
CAS No.57626-36-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACRVQQ038 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRVQQ038 route product structure diagram
    ACRVQQ03857626-36-5In Stock
Inquiry

2. ACRVQQ038 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRVQQ038 route product structure diagram
    ACRVQQ03857626-36-5In Stock
Inquiry

3. ACRVQQ038 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRVQQ038 route product structure diagram
    ACRVQQ03857626-36-5In Stock
Inquiry

Comments (0)